EU Regulatory Update: Where Do We Stand Now – On Shaky Ground?
Most EU regulators are now back in the swing of work after their summer break and the conference season is heating up. What are the key issues likely to top the agenda over the next few months?
You may also be interested in...
Some of the EU's most critical medtech standards have been coming under criticism for more than half a decade. Now, the European Commission is making key changes, but the timing could not be worse for the sector.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies